Quality control of right heart catheterization for pulmonary vascular diseases in China
Official title: China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-A Quality Control on Right Heart Catheterization
Run by China-Japan Friendship Hospital · NCT06954727 · Data updated 2026-11-12
This study looks at the quality of right heart catheterization procedures for people with suspected pulmonary hypertension in China to see how well they are being done and what outcomes patients experience.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 14 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | January 1, 2018 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2030 |
| Registry record updated | May 21, 2025 |
| Trial ID | NCT06954727 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 14 years or older who are undergoing right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension.
✕Probably not a fit
Patients who have missing vital data or who do not consent to follow-up will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on the quality control of right heart catheterization (RHC) across multiple pulmonary hypertension centers in China. It aims to collect and analyze data from patients aged 14 and older who undergo RHC due to dyspnea or suspected pulmonary hypertension. The study will gather both retrospective and prospective data, including hemodynamic parameters, diagnostic classifications, and treatment plans, while ensuring routine follow-up for participants. The data will be managed through an Electronic Data Capture system to facilitate quality control and statistical analysis.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and management of pulmonary vascular diseases in China, leading to improved patient outcomes.
How similar studies have gone: While this study addresses a critical gap in the implementation of right heart catheterization in China, similar studies have shown success in other regions, indicating the potential for positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent right heart catheterization for the first time due to dyspnea or suspected pulmonary hypertension * Age ≥14 years old Exclusion Criteria: * Vital data missing * Did not sign informed consent or did not agree to follow-up
Where it's running
-
China-Japan Friendship Hospital
Beijing, China Recruiting
Study contacts
- Principal investigator: Zhenguo Zhai, PhD — China-Japan Friendship Hospital
- Study coordinator: Zhenguo Zhai
- Email: zhaizhenguo2011@126.com
- Phone: 010-8420-6265
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rutgers Genetics of Pulmonary Hypertension
This online project will try to see if genetic differences affect the risk of pulmonary hypertension in U.S. adults, and anyone 18 or older can join whether or not they have PH.
-
129Xe MRI to monitor sotatercept treatment in pulmonary arterial hypertension
This will test whether hyperpolarized 129Xe MRI scans can noninvasively track lung blood-vessel improvement in adults with pulmonary arterial hypertension treated with sotatercept.
-
Using artificial intelligence to evaluate pulmonary hypertension
This study is testing if using artificial intelligence with different medical tests can help doctors find pulmonary hypertension earlier and more accurately in patients.
-
Using Xenon MRI to study pulmonary hypertension
This study is testing if a special type of MRI can help understand how lung changes in people with pulmonary arterial hypertension affect their breathing and overall health.
-
Registry and biorepository for pulmonary hypertension patients
This study is setting up a collection of health information and blood samples from people with pulmonary hypertension to help researchers learn more about the disease and improve treatments.
-
Treatment for pulmonary arterial hypertension using a new device
This study is testing a new device to see if it can safely help people with pulmonary hypertension and right heart problems feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.